When baseline characteristics were compared between patients who did or did not respond to oral iron by week 4, there were no marked differences in age, gender, renal function (as assessed by eGFR), presence of diabetes or hypertension, or CRP level (Table 1). This evidence concerns the gene CRP and diabetes mellitus.